{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:27:14Z","timestamp":1780507634689,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.dld.2017.10.014","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T19:33:50Z","timestamp":1509132830000},"page":"181-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Long-term course of precancerous lesions arising in patients with gastric MALT lymphoma"],"prefix":"10.1016","volume":"50","author":[{"given":"Anne-Laure","family":"Rentien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl","family":"L\u00e9vy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Copie-Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Gagniere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehan","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Le Baleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Belhadj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iradj","family":"Sobhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Haioun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Delchier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6676-1222","authenticated-orcid":false,"given":"Aurelien","family":"Amiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2017.10.014_bib0005","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1053\/j.gastro.2014.01.001","article-title":"Gastrointestinal malignancy and the microbiome","volume":"146","author":"Abreu","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.10.014_bib0010","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","article-title":"Global burden of cancers attributable to infections in 2012: a synthetic analysis","volume":"4","author":"Plummer","year":"2016","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.dld.2017.10.014_bib0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/j.gastro.2015.09.004","article-title":"Pathobiology of helicobacter pylori-induced gastric cancer","volume":"150","author":"Amieva","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2017.10.014_bib0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.291.2.187","article-title":"Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial","volume":"291","author":"Wong","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.dld.2017.10.014_bib0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/17474124.2014.859522","article-title":"Evidence-based recommendations for successful Helicobacter pylori treatment","volume":"8","author":"Wu","year":"2014","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2017.10.014_bib0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.semcancer.2013.11.005","article-title":"Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type","volume":"24","author":"Thieblemont","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.dld.2017.10.014_bib0035","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/gutjnl-2011-300495","article-title":"Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan","volume":"61","author":"Nakamura","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.10.014_bib0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4143\/crt.2014.46.1.33","article-title":"The role of radiotherapy in the treatment of gastric mucosa-associated lymphoid tissue lymphoma","volume":"46","author":"Nam","year":"2014","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.dld.2017.10.014_bib0045","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2015.08.029","article-title":"Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: results of a prospective study with a long term follow-up","volume":"117","author":"Ruskon\u00e9-Foumestraux","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.dld.2017.10.014_bib0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12032-009-9207-y","article-title":"Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy: a pooled data analysis","volume":"27","author":"Zullo","year":"2010","journal-title":"Med Oncol"},{"key":"10.1016\/j.dld.2017.10.014_bib0055","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/apt.12635","article-title":"Rituximab, alkylating agents or combination therapy for gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomised observational study","volume":"39","author":"Amiot","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"17","key":"10.1016\/j.dld.2017.10.014_bib0060","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1200\/JCO.2016.70.6994","article-title":"Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy","volume":"35","author":"Zucca","year":"2017","journal-title":"J Clin Oncol"},{"issue":"Suppl. 6","key":"10.1016\/j.dld.2017.10.014_bib0065","doi-asserted-by":"crossref","first-page":"vi144","DOI":"10.1093\/annonc\/mdt343","article-title":"Gastric marginal zone lymphoma of MALT type: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Zucca","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.dld.2017.10.014_bib0070","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/annonc\/mdi242","article-title":"Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma?","volume":"16","author":"Copie-Bergman","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.dld.2017.10.014_bib0075","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2559.1995.tb01522.x","article-title":"Synchronous adenocarcinoma and low grade B-cell lymphoma of mucosa associated lymphoid tissue (MALT) of the stomach","volume":"27","author":"Wotherspoon","year":"1995","journal-title":"Histopathology"},{"issue":"January","key":"10.1016\/j.dld.2017.10.014_bib0080","first-page":"1","article-title":"Second primary malignancies in patients treated for gastric mucosa-associated lymphoid tissue lymphoma","author":"Amiot","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.dld.2017.10.014_bib0085","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/j.1572-0241.2006.00671.x","article-title":"Frequent and rapid progression of atrophy and intestinal metaplasia in gastric mucosa of patients with MALT lymphoma","volume":"101","author":"Lamarque","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2017.10.014_bib0090","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"214","article-title":"Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)","author":"Isaacson","year":"2008"},{"key":"10.1016\/j.dld.2017.10.014_bib0095","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00000478-200101000-00011","article-title":"Prognostic significance of the histopathologic recognition of low- and high-grade components in stage I\u2013II B-cell gastric lymphomas","volume":"25","author":"Ferreri","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.dld.2017.10.014_bib0100","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3109\/10428194.2012.729832","article-title":"Rituximab and chlorambucil versus rituximab alone in gastric mucosa-associated lymphoid tissue lymphoma according to t(11;18) status: a monocentric non-randomized observational study","volume":"54","author":"L\u00e9vy","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.dld.2017.10.014_bib0105","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994","volume":"20","author":"Dixon","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.dld.2017.10.014_bib0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00000478-200002000-00001","article-title":"Gastric dysplasia: the Padova international classification","volume":"24","author":"Rugge","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.dld.2017.10.014_bib0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00428-002-0680-3","article-title":"The new Vienna classification of epithelial neoplasia of the gastrointestinal tract: advantages and disadvantages","volume":"442","author":"Stolte","year":"2003","journal-title":"Virchows Arch Int J Pathol"},{"key":"10.1016\/j.dld.2017.10.014_bib0120","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0369-8114(01)00209-7","article-title":"Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole\u2013amoxicillin\u2013clarithromycin therapy","volume":"49","author":"Tankovic","year":"2001","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.dld.2017.10.014_bib0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/bjh.12078","article-title":"Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice","volume":"160","author":"Copie-Bergman","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.dld.2017.10.014_bib0130","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/gut.52.11.1656","article-title":"Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma","volume":"52","author":"Copie-Bergman","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.10.014_bib0135","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/gut.2010.224949","article-title":"EGILS consensus report: gastric extranodal marginal zone B-cell lymphoma of MALT","volume":"60","author":"Ruskon\u00e9-Fourmestraux","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.dld.2017.10.014_bib0140","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.06.035","article-title":"Second cancers and residual disease in patients treated for gastric mucosa-associated lymphoid tissue lymphoma by Helicobacter pylori eradication and followed for 10 years","volume":"143","author":"W\u00fcndisch","year":"2012","journal-title":"Gastroenterology"},{"issue":"44","key":"10.1016\/j.dld.2017.10.014_bib0145","first-page":"2470","article-title":"Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study","volume":"2008","author":"Capelle","year":"1990","journal-title":"Eur J Cancer Oxf Engl"},{"issue":"Suppl. 2","key":"10.1016\/j.dld.2017.10.014_bib0150","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1523-5378.2007.00563.x","article-title":"The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis","volume":"12","author":"Rokkas","year":"2007","journal-title":"Helicobacter"},{"issue":"1","key":"10.1016\/j.dld.2017.10.014_bib0155","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s10120-015-0462-7","article-title":"Helicobacter pylori eradication cannot reduce 498 the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis","volume":"19","author":"Chen","year":"2016","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.dld.2017.10.014_bib0160","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.critrevonc.2007.01.003","article-title":"Primary diffuse large B-cell lymphoma of the stomach","volume":"63","author":"Ferreri","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.dld.2017.10.014_bib0165","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1158\/1078-0432.CCR-15-2305","article-title":"Next-generation sequencing in diffuse large B-cell lymphoma highlights molecular divergence and therapeutic opportunities: a LYSA study","volume":"22","author":"Dubois","year":"2016","journal-title":"Clin Cancer"},{"key":"10.1016\/j.dld.2017.10.014_bib0170","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nrgastro.2010.58","article-title":"Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development","volume":"7","author":"Sagaert","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2017.10.014_bib0175","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1198946","article-title":"Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation","volume":"331","author":"Rosebeck","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.dld.2017.10.014_bib0180","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nri1629","article-title":"Control of lymphocyte development by nuclear factor-kappaB","volume":"5","author":"Siebenlist","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.dld.2017.10.014_bib0185","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1038\/onc.2013.380","article-title":"Helicobacter pylori generates cells with cancer stem cell properties via epithelial\u2013mesenchymal transition-like changes","volume":"33","author":"Bessede","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.dld.2017.10.014_bib0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.beha.2017.01.002","article-title":"Clinical aspects and therapy of gastrointestinal MALT lymphoma","volume":"30","author":"Thieblemont","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.dld.2017.10.014_bib0195","first-page":"74","volume":"44","author":"Dinis-Ribeiro","year":"2011","journal-title":"Endoscopy"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817312653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817312653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T17:40:45Z","timestamp":1603215645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865817312653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1590865817312653"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2017.10.014","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term course of precancerous lesions arising in patients with gastric MALT lymphoma","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2017.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}